Hollister Biosciences Stock Down Slightly On $17.6M Q2 2021 Revenue Report, $3.2M Of Adjusted EBITDA
Cannabis branding company Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) reported its financial and operating results on Thursday for the second quarter of 2021, touting a significant growth in revenue which amounted to $17.6 million.